These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11055656)

  • 1. Plasmapheresis as part of the treatment for septic shock.
    Hjorth V; Stenlund G
    Scand J Infect Dis; 2000; 32(5):511-4. PubMed ID: 11055656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial.
    Busund R; Koukline V; Utrobin U; Nedashkovsky E
    Intensive Care Med; 2002 Oct; 28(10):1434-9. PubMed ID: 12373468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis in the treatment of primary septic shock in humans.
    Gårdlund B; Sjölin J; Nilsson A; Roll M; Wickerts CJ; Wikström B; Wretlind B
    Scand J Infect Dis; 1993; 25(6):757-61. PubMed ID: 8052817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood exchange and plasmapheresis in sepsis and septic shock.
    Pollack M
    Clin Infect Dis; 1992 Sep; 15(3):431-3. PubMed ID: 1520789
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasmapheresis in the treatment of septic shock].
    Busund R
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):776-8. PubMed ID: 15039806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock.
    Ataman K; Jehmlich M; Kock S; Neumann S; Leischik M; Filipovic Z; Hopf HB
    Intensive Care Med; 2002 Aug; 28(8):1164-7. PubMed ID: 12185443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of bacteria by continuous renal replacement therapy in septic shock and by ultrafiltration from an in vitro model of bacteremia.
    Hansard PC; Haseeb MA; Manning RA; Salwen MJ
    Crit Care Med; 2004 Apr; 32(4):932-7. PubMed ID: 15071381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.
    McCloskey RV; Straube RC; Sanders C; Smith SM; Smith CR
    Ann Intern Med; 1994 Jul; 121(1):1-5. PubMed ID: 8198341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular parameters and scoring systems in the evaluation of response to therapy in sepsis and septic shock.
    Pilz G; Werdan K
    Infection; 1990; 18(5):253-62. PubMed ID: 2276817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of septic shock in patients with methicillin-resistant Staphylococcus aureus bacteremia.
    Lam SW; Bauer SR; Neuner EA
    Int J Infect Dis; 2012 Jun; 16(6):e453-6. PubMed ID: 22497963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical sepsis trials.
    Abraham E
    Chest; 1994 Mar; 105(3 Suppl):53S-55S. PubMed ID: 8131613
    [No Abstract]   [Full Text] [Related]  

  • 12. [Complex correction of intoxication syndrome in sepsis].
    Torbinskiĭ AM
    Klin Khir (1962); 1991; (1):27-30. PubMed ID: 2067224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogens and outcomes in pediatric septic shock patients supported by extracorporeal membrane oxygenation.
    Chang TH; Wu ET; Lu CY; Huang SC; Yang TI; Wang CC; Chen JM; Lee PI; Huang LM; Chang LY
    J Microbiol Immunol Infect; 2018 Jun; 51(3):385-391. PubMed ID: 28821378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units.
    Lundberg JS; Perl TM; Wiblin T; Costigan MD; Dawson J; Nettleman MD; Wenzel RP
    Crit Care Med; 1998 Jun; 26(6):1020-4. PubMed ID: 9635649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe pediatric sepsis.
    Nadel S
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):111-4. PubMed ID: 22339183
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects during treatment of sepsis and septic shock with immunoglobulins and plasma-pheresis.
    Werdan K; Pilz G; Kääb S
    Prog Clin Biol Res; 1989; 308():1025-30. PubMed ID: 2780684
    [No Abstract]   [Full Text] [Related]  

  • 18. Steroids in the treatment of clinical septic shock.
    Schumer W
    Ann Surg; 1976 Sep; 184(3):333-41. PubMed ID: 786190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution over a 15-year period of clinical characteristics and outcomes of critically ill patients with community-acquired bacteremia.
    Vallés J; Palomar M; Alvárez-Lerma F; Rello J; Blanco A; Garnacho-Montero J; Martín-Loeches I;
    Crit Care Med; 2013 Jan; 41(1):76-83. PubMed ID: 23222266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year mortality of bloodstream infection-associated sepsis and septic shock among patients presenting to a regional critical care system.
    Laupland KB; Zygun DA; Doig CJ; Bagshaw SM; Svenson LW; Fick GH
    Intensive Care Med; 2005 Feb; 31(2):213-9. PubMed ID: 15666140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.